NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer
De La Cruz P, McAdams J, Morales Aquino M, Fernandez A, Elliott A, Lustberg M, Schorl C, Ribeiro J, James N. NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer. Breast Cancer Research 2024, 26: 175. PMID: 39623404, PMCID: PMC11613493, DOI: 10.1186/s13058-024-01925-3.Peer-Reviewed Original ResearchConceptsNegative breast cancerBreast cancerAggressive subtypePrognostic markerBeta expressionMouse modelPD-1-based immunotherapyMetastatic triple negative breast cancerAggressive subtype of breast cancerBackgroundTriple negative breast cancerAssociated with tumor regressionSubtypes of breast cancerTriple negative breast cancerSyngeneic mouse modelSerum cytokine profilesMarker of prognosisPatient clinical outcomesTargeted treatment approachesMetastatic settingPD-1Tumor regressionTNBC cohortFrontline chemotherapySurvival outcomesCytokine profile
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply